Cargando…

Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer

The treatment of cancer is becoming more precise, targeting specific oncogenic drivers with targeted molecular therapies. The epidermal growth factor receptor has been found to be over-expressed in a multitude of solid tumours. Immunohistochemistry is widely used in the fields of diagnostic and pers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hutchinson, Ryan A, Adams, Richard A, McArt, Darragh G, Salto-Tellez, Manuel, Jasani, Bharat, Hamilton, Peter W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492076/ https://www.ncbi.nlm.nih.gov/pubmed/26149458 http://dx.doi.org/10.1186/s12967-015-0531-z

Ejemplares similares

cudaMap: a GPU accelerated program for gene expression connectivity mapping
por: McArt, Darragh G, et al.
Publicado: (2013)

The prognostic value of the stem-like group in colorectal cancer using a panel of immunohistochemistry markers
por: Ong, Chee Wee, et al.
Publicado: (2015)

Translation of tissue-based artificial intelligence into clinical practice: from discovery to adoption
por: Geaney, Alice, et al.
Publicado: (2023)

Connectivity Mapping for Candidate Therapeutics Identification Using Next Generation Sequencing RNA-Seq Data
por: McArt, Darragh G., et al.
Publicado: (2013)

Embracing an integromic approach to tissue biomarker research in cancer: Perspectives and lessons learned
por: Li, Gerald, et al.
Publicado: (2017)

Stratified analysis reveals chemokine-like factor (CKLF) as a potential prognostic marker in the MSI-immune consensus molecular subtype CMS1 of colorectal cancer
por: Dunne, Philip D., et al.
Publicado: (2016)

Validation of Next Generation Sequencing Technologies in Comparison to Current Diagnostic Gold Standards for BRAF, EGFR and KRAS Mutational Analysis
por: McCourt, Clare M., et al.
Publicado: (2013)

Molecular classification of non-invasive breast lesions for personalised therapy and chemoprevention
por: Buckley, Niamh, et al.
Publicado: (2015)

Quantification of HER2 heterogeneity in breast cancer–implications for identification of sub-dominant clones for personalised treatment
por: Buckley, Niamh E., et al.
Publicado: (2016)

Identification of Candidate Small-Molecule Therapeutics to Cancer by Gene-Signature Perturbation in Connectivity Mapping
por: McArt, Darragh G., et al.
Publicado: (2011)

Evolutionary genetic algorithm identifies IL2RB as a potential predictive biomarker for immune-checkpoint therapy in colorectal cancer
por: Alderdice, Matthew, et al.
Publicado: (2021)

NUQA: Estimating Cancer Spatial and Temporal Heterogeneity and Evolution through Alignment-Free Methods
por: Roddy, Aideen C, et al.
Publicado: (2019)

Transcriptional Profiling of a Patient-Matched Cohort of Glioblastoma (IDH-Wildtype) for Therapeutic Target and Repurposing Drug Identification
por: Roddy, Aideen C., et al.
Publicado: (2023)

QuPath: Open source software for digital pathology image analysis
por: Bankhead, Peter, et al.
Publicado: (2017)

KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies
por: Wen, Qing, et al.
Publicado: (2016)

Automated tumor analysis for molecular profiling in lung cancer
por: Hamilton, Peter W., et al.
Publicado: (2015)

Relative Prognostic Value of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Operable Oesophagogastric Cancer
por: Chan, David S. Y., et al.
Publicado: (2012)

Epidermal growth factor receptor in ovarian tumours: correlation of immunohistochemistry with ligand binding assay.
por: Henzen-Logmans, S. C., et al.
Publicado: (1992)

TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.
por: D'Costa, Zenobia C., et al.
Publicado: (2014)

A study of human epidermal growth factor receptor 2 overexpression by immunohistochemistry in patients with gastric adenocarcinoma
por: ABOOD, RAFID A., et al.
Publicado: (2023)

IHC-based subcellular quantification provides new insights into prognostic relevance of FLIP and procaspase-8 in non-small-cell lung cancer
por: Hutchinson, Ryan A, et al.
Publicado: (2017)

Prognostic and therapeutic relevance of FLIP and procaspase-8 overexpression in non-small cell lung cancer
por: Riley, J S, et al.
Publicado: (2013)

Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxia
por: Craig, Stephanie G., et al.
Publicado: (2020)

Transcriptional Subtyping and CD8 Immunohistochemistry Identifies Patients With Stage II and III Colorectal Cancer With Poor Prognosis Who Benefit From Adjuvant Chemotherapy
por: Allen, Wendy L., et al.
Publicado: (2018)

Plant Defenses and Predation Risk Differentially Shape Patterns of Consumption, Growth, and Digestive Efficiency in a Guild of Leaf-Chewing Insects
por: Kaplan, Ian, et al.
Publicado: (2014)

Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility
por: Alvi, Muhammad A., et al.
Publicado: (2015)

Robustness of differential gene expression analysis of RNA-seq
por: Stupnikov, A., et al.
Publicado: (2021)

NM-23 H1 immunohistochemistry is not useful as predictor of metastatic potential of colorectal cancer.
por: Lindmark, G.
Publicado: (1996)

Comparison of the Mismatch Repair System between Primary and Metastatic Colorectal Cancers Using Immunohistochemistry
por: Jung, Jiyoon, et al.
Publicado: (2017)

Novel deep learning-based solution for identification of prognostic subgroups in liver cancer (Hepatocellular carcinoma)
por: Owens, Alice R., et al.
Publicado: (2021)

Impact of Variable RNA-Sequencing Depth on Gene Expression Signatures and Target Compound Robustness: Case Study Examining Brain Tumor (Glioma) Disease Progression
por: Stupnikov, Alexey, et al.
Publicado: (2018)

Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast Cancer
por: Humphries, Matthew P., et al.
Publicado: (2018)

Commentary: Guideline for Performing Human Epidermal Growth Factor Receptor 2 Immunohistochemistry Quantitative Image Analysis well
por: Beckwith, Bruce
Publicado: (2019)

Transcriptional upregulation of c-MET is associated with invasion and tumor budding in colorectal cancer
por: Bradley, Conor A., et al.
Publicado: (2016)

Prospective patient stratification into robust cancer‐cell intrinsic subtypes from colorectal cancer biopsies
por: Alderdice, Matthew, et al.
Publicado: (2018)

ICOSeg: Real-Time ICOS Protein Expression Segmentation from Immunohistochemistry Slides Using a Lightweight Conv-Transformer Network
por: Singh, Vivek Kumar, et al.
Publicado: (2022)

Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor–Targeted Therapy in Metastatic Colorectal Cancer
por: Siena, Salvatore, et al.
Publicado: (2009)

Enzyme-linked immunosorbent assay of epidermal growth factor receptor in lung cancer: comparisons with immunohistochemistry, clinicopathological features and prognosis.
por: Pfeiffer, P., et al.
Publicado: (1998)

Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma
por: Halse, H., et al.
Publicado: (2018)

Erratum to “Blood calcium as a prognostic indicator of success after surgical correction of left displaced abomasum” (JDS Commun. 2:207–211)
por: Bach, K.D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m90ddvtffp604i8i4v7s118i59